Harnessing the power of Imaging Phenomics

At Median, we’re transforming the science of medical imaging. By harnessing the power of Imaging Phenomics we can improve current treatment, enhance diagnosis and accelerate development of next generation therapies, helping make a healthier world for millions.

The fight against disease is a joint effort

While our expertise and resources are unique, we don’t work alone. The fight against disease is a joint effort and the spirit of cooperation is found in everything we do. Whether working in clinical trials or patient care and treatment, we share the same single-minded goal. To defeat the diseases that still touch so many lives.

Pushing the boundaries of imaging technology

At Median we’re determined to push the boundaries of what imaging technology can achieve, to help develop next generation treatments with the potential to save or improve the lives of millions.

CEO’s message


Fredrik Brag talks about how we’re looking to change the game. To transform the landscape in which we work and create a new world of possibilities for biopharma companies and healthcare professionals alike.

Read more

The Imaging Phenomics Company®

Median Technologies is the Imaging Phenomics Company®. Learn about our MediScan® portfolio for Patient Care, our Lesion Management Solution (LMS) technology and iBiopsy®, our Imaging Biomarker Phenotyping System.

Watch

News

31 May 2018

Median Technologies to attend the 2018 ASCO Annual Meeting, June 1-5, 2018, McCormick Place, Chicago, IL, USA

Median Technologies will share and showcase its offering for imaging solutions and services in clinical trials, featuring iSee®, their next generation image analysis and management platform, and ImageBank™, their latest solution for Phase I Cancer Centers, at booth #6106.

24 May 2018

Median Technologies appoints Dr. Yan Liu as Medical Director, Europe

Press Release – For immediate release – 5:45p. CEST Median Technologies appoints Dr. Yan Liu as Medical Director, Europe Dr. Yan Liu will…

26 April 2018

Median Technologies launches ImageBank™

Median Technologies launches ImageBank™ – New service offering enables efficient medical image collection and storage for Phase I oncology clinical trials.

12 April 2018

Median Technologies Reports Full Year 2017 Financial Results

Revenues increased 21% to €7.69 million for the full year 2017. Net new business of €14.69 million, increased backlog by 23% to €23 million for the full year. Cash and cash equivalents are €28.29 million, as of December 31, 2017

12 March 2018

Median Technologies and the Nice University Hospital (CHU de Nice) announce agreement to advance lung cancer screening with Artificial Intelligence

Median Technologies and the Nice University Hospital (CHU de Nice) announce agreement to advance lung cancer screening with Artificial Intelligence. Collaboration will use Deep Learning techniques to establish medical imaging biomarkers for more accurate diagnosis

1/5

Opinion

18 June 2018
ASCO 2018: Headlines and Highlights

ASCO 2018: Headlines and Highlights

ASCO 2018: Headlines and Highlights All eyes were on the American Society of Clinical Oncology (ASCO) Annual conference last week in Chicago watching…

15 May 2018
Immunotherapy Update: Recent Advances in CAR T-cell Therapy

Immunotherapy Update: Recent Advances in CAR T-cell Therapy

Immunotherapy Update: Recent Advances in CAR T-cell Therapy As a measure of its promise, chimeric antigen receptor (CAR) T-cell therapy – where patients’…

14 March 2018
Industry Trends:  AI Revolutionizes Imaging Analysis

Industry Trends: AI Revolutionizes Imaging Analysis

Industry Trends:  AI Revolutionizes Imaging Analysis The radiology industry is embracing artificial intelligence (AI) to enhance image analysis, and it’s having a profound impact…

9 January 2018
The Value of Standardized Quality and Performance Metrics in Clinical Trials

The Value of Standardized Quality and Performance Metrics in Clinical Trials

The Value of Standardized Quality and Performance Metrics in Clinical Trials It’s not just tumor measurements that matter! Quality and Performance Measurements are…

12 October 2017
Different Types of Imaging Criteria: Morphological Measures

Different Types of Imaging Criteria: Morphological Measures

Different Types of Imaging Criteria: Morphological Measures In oncology clinical trials, therapy is generally assessed using imaging response criteria involving imaging biomarkers. Imaging…

1/5
Imaging for patient care

Identifying treatments that work

Imaging biomarkers provide a unique insight into treatment progress at every stage of a disease. In cancer for instance, comprehensive quantitative information plays an invaluable role in defining, tracking and measuring treatment outcomes. Providing clear evidence of what works and what doesn’t.

Read more

Imaging for clinical trials

Advancing treatments of the future

Working with biopharmaceutical companies, and leading medical centers around the world, the team at Median enable researchers to identify disease fingerprints from medical images. We’re helping paving the way for new personalized and innovative medicines, more accurate and predictable diagnoses and better treatments

Read more

Ibiopsy®

Powering the phenomics revolution

We’re changing the game; transforming the landscape. We’re capturing the power of big data and unique biomarker imaging technology to create a new world of possibilities for biopharma and healthcare professionals alike. Our iBiopsy® platform opens up the field of phenomics, driving the science of precision medicine.

Read more

Investors

Delivering value

Our technology and expertise is creating a new world of possibilities for biopharmaceutical and healthcare professionals around the world. By successfully helping improve the lives of millions, we are also delivering value for our investors and partners.

Read more

Stock Market Data

TICKER: ALMDT ISIN: FR0011049824
Get in touch
Europe
United States
China

china

12/F Platinum Tower
233 Tai Cang Road
Shanghai 200020
China

europe

Median Technologies
Les Deux Arcs, Bât B
1800, route des Crêtes
06560 Valbonne
France

United States

Legal address
Median Technologies Inc
C/O Pramex International
1251 Avenue of the Americas
3rd Floor
New York NY 10020

US offices

Median Technologies Inc
300 TradeCenter
Suite 5610
Woburn MA 01801

Get in touch

Get in touch





Jobs at Median

Cookies help us deliver our services. By using our services, you agree to our use of cookies.